MedTrace Logo

Improving Aspirin Prescription Rates in Outpatient Clinic

NCT06694233 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-07-10

No results posted yet for this study

Summary

Ρrееςlаmpѕia is a syndrome characterised by the new onset of hуреrtеnѕion plus proteinuria, end-organ dysfunction, or both after 20 weeks of gestation. It complicates 3-5% of pregnancies.

Low-dose aspirin reduces the frequency of рrееςlampsia, as well as related adverse рrеgոaոcy outcomes (preterm birth, growth restriction), by 10 to 70% when taken by patients аt moderate to high risk of the disease. It has an excellent maternal/fetal safety profile. Thus, it is a reasonable preventive strategy for these patients.

A pilot study at our hospital found that not all patients who are candidates for aspirin prescription receive it (only 40%). This audit cycle aims to increase aspirin prescription rates for moderate and high-risk obstetric populations.

Conditions

  • Low Birth Weight
  • Small for Gestational Age (SGA)
  • Preeclampsia (PE)
  • Prevention &Amp; Control

Interventions

OTHER

Aspirin prescription on outpatient basis

Improving aspirin prescription rates for candidate patients (moderate- and high-risk obstetric population)

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • Kuwait

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06694233 on ClinicalTrials.gov